Coronavirus (COVID-19) And Medical Malpractice: FDA’s Warning Regarding Fraudulent Prevention/Treatment Claims
The FDA issued a press release on March 9, 2020 stating, in part: “The U.S. Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) issued warning letters to seven companies for selling fraudulent COVID-19 products. These products are unapproved drugs that pose significant ri[...]
